drugset / Trial / NCT00964743
Depocyt® With Sorafenib in Neoplastic Meningitis
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the tolerability and side effects of oral sorafenib in combination with intrathecal DepoCyt.
Timeline
- Start
- 2009-08
- Primary completion
- 2011-02
- Completion
- 2011-02
Outcome
Outcome not reported
Stopped (Enrollment): “Low Accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cytarabine | Small molecule | — | Intrathecal |
| Subject | Sorafenib | Small molecule | 400 mg | Oral |